In the study of congenital hyperinsulinism now enrolling phase III sunRIZE trial

sunrize logo

Rezolute to Initiate a Pivotal Phase 3 Study of RZ358 in Participants 3 Months of Age and Older With Congenital Hyperinsulinism

Back to Careers